Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

The annual New York Sportsman’s Expo returns to the Exposition Center at the NYS Fairgrounds this weekend, Jan. 24-26. Hours are 12-7 Friday, 9-7 Saturday, and 9-5 Sunday. You can buy tickets ...

If you buy something, we may earn an affiliate commission. Tailored jackets are a keystone species in the menswear ecosystem, but there’s a lot more to them than meets the eye. For one thing ...

Prairie Sportsman celebrates our love of the outdoors to hunt, fish and enjoy outdoor recreation provided by our vast resources of lakes, rivers, trails and grasslands. Here, we connect with the ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The latest fashion news, beauty coverage, celebrity style, fashion week updates, culture reviews, and videos on Vogue.com.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...